自身免疫性肝炎自身抗体的研究进展

张海萍; 闫惠平

doi:10.3969/j.issn.1001-5256.2020.04.007

自身免疫性肝炎自身抗体的研究进展

DOI: 10.3969/j.issn.1001-5256.2020.04.007

首都医科大学附属北京佑安医院临床检验中心自身免疫性肝病临床研究中心

详细信息

中图分类号: R575.1
计量
- 文章访问数: 1577
- HTML全文浏览量: 42
- PDF下载量: 441
- 被引次数: 0
出版历程
- 收稿日期: 2020-02-02
- 出版日期: 2020-04-20

Research advances in autoantibodies in autoimmune hepatitis

Clinical Laboratory Center,Clinical Research Center for Autoimmune Liver Disease,Beijing YouAn Hospital,Capital Medical University

摘要

摘要: 自身抗体对自身免疫性肝炎(AIH)的诊断、分型和鉴别诊断具有重要的价值。但AIH的自身抗体存在缺乏疾病特异性、种类多且检测结果不一致等问题,给临床诊断带来困惑。基于文献数据和笔者临床经验,对AIH的主要自身抗体应用价值和研究进展、相关指南对自身抗体检测方法的推荐意见等进行简单介绍。
- 肝炎,自身免疫性 /
- 自身抗体 /
- 诊断,鉴别
Abstract: Autoantibodies have an important value in the diagnosis,typing,and differential diagnosis of autoimmune hepatitis( AIH); however,the autoantibodies of AIH lack specificity and have various types and inconsistent results,which brings confusions to clinical diagnosis.With reference to the literature data and the author's clinical experience,this article reviews the application value and research advances in the main autoantibodies in AIH and introduces the recommendations for autoantibody detection methods in related guidelines.
- hepatitis,autoimmune /
- autoantibodies /
- diagnosis,differential

HTML全文

参考文献(28)

[1] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association; Chinese Society of Infectious Diseases,Chinese Medical Association. Consensus on the diagnosis and management of autoimmune hepatitis(2015)[J]. J Clin Hepatol,2016,32(1):9-22.(in Chinese)中华医学会肝病学分会，中华医学会消化病学分会，中华医学会感染病学分会．自身免疫性肝炎诊断和治疗共识(2015)[J]．临床肝胆病杂志，2016,32(1):9-22.

[2] European Association for the Study of the Liver. EASL-autoimmune hepatitis-clinical practice guideline[J]. J Hepatol,2015,63(4):971-1004.

[3] MACK CL,ADAMS D,ASSIS DN,et al. Diagnosis and management of autoimmune hepatitis in adults and children:2019practice guidance and guidelines from the American Association for the study of liver diseases[J]. Hepatology,2019.[Epub ahead of print]

[4] Special Committee of Autoantibody Detection,Chinese Association of Rheumatology&Immunology Physicians, Chinese Medical Doctor Association. Expert consensus on the clinical application of antinuclear antibody[J]. Chin J Lab Med,2018,41(4):275-280.(in Chinese)中国医师协会风湿免疫科医师分会自身抗体检测专业委员会．抗核抗体检测的临床应用专家共识[J]．中华检验医学杂志，2018,41(4):275-280.

[5] CHAN EK,DAMOISEAUX J,CARBALLO OG,et al. Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015[J].Front Immunol,2015,6:412.

[6] MIELI-VERGANI G,VERGANI D,CZAJA AJ,et al. Autoimmune hepatitis[J]. Nat Rev Dis Primers,2018,4:18017.

[7] European Association for the Study of the Liver. EASL clinical practice guidelines:The diagnosis and management of patients with primary biliary cholangitis[J]. J Hepatol,2017,67(1):145-172.

[8] ALVAREZ F,BERG PA,BIANCHI FB,et al. International autoimmune hepatitis group report:Review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol,1999,31(5):929-938.

[9] HENNES EM,ZENIYA M,CZAJA AJ,et al. Simplified criteria for the diagnosis of autoimmune hepatitis[J]. Hepatology,2008,48(1):169-176.

[10] YAN HP,JIA JD. Autoimmune liver disease[M]. Beijing:People’s Medical Publishing House,2018.(in Chinese)闫惠平，贾继东．自身免疫性肝脏疾病[M]．北京:人民卫生出版社，2018.

[11] TERZIROLI BERETTA-PICCOLI B,MIELI-VERGANI G,VERGANI D. Serology in autoimmune hepatitis:A clinical-practice approach[J]. Eur J Intern Med,2018,48:35-43.

[12] SHIBUKI T,OTSUKA T,ISODA H,et al. Seropositivity and titers of anti-smooth muscle actin antibody are associated with relapse of type 1 autoimmune hepatitis[J]. Med Sci Monit,2017,23:4028-4033.

[13] COUTO CA,BITTENCOURT PL,PORTA G,et al. Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis[J].Hepatology,2014,59(2):592-600.

[14] GUGUEN P,DALEKOS G,NOUSBAUM JB,et al. Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1[J]. J Clin Immunol,2006,26(6):495-505.

[15] ZACHOU K,OIKONOMOU K,RENAUDINEAU Y,et al. Anti-αactinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1[J]. Aliment Pharmacol Ther,2012,35(1):116-125.

[16] MANNS M,GERKEN G,KYRIATSOULIS A,et al. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen[J]. Lancet,1987,1(8528):292-294.

[17] WIES I,BRUNNER S,HENNINGER J,et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis[J]. Lancet,2000,355(9214):1510-1515.

[18] PALIOURA S,SHERRER RL,STEITZ TA,et al. The human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation[J]. Science,2009,325(5938):321-325.

[19] JOHANET C,BALLOT E. Auto-antibodies in autoimmune hepatitis:Anti-soluble liver antigen(SLA)[J]. Clin Res Hepatol Gastroenterol,2012,36(3):244-246.

[20] TERZIROLI BERETTA-PICCOLI B,MIELI-VERGANI G,VERGANI D. The clinical usage and definition of autoantibodies in immune-mediated liver disease:A comprehensive overview[J]. J Autoimmun,2018,95:144-158.

[21] ZHAGN HP,MA YX,LI LJ,et al. Analysis of the autoantibodies characteristics of 77 anti-soluble liver antigen positive patients with liver diseases[J]. Chin J Lab Med,2019,42(11):927-932.(in Chinese)张海萍，马胤雪，李丽娟，等．77例抗可溶性肝抗原抗体阳性肝病患者的自身抗体特征分析[J]．中华检验医学杂志，2019,42(11):927-932.

[22] ZACHOU K,WEILER-NORMANN C,MURATORI L,et al.Permanent immunosuppression in SLA/LP-positive autoimmune hepatitis is required although overall response and survival are similar[J]. Liver Int,2020,40(2):368-376.

[23] CHEN ZX,SHAO JG,SHEN Y,et al. Prognostic implications of antibodies to soluble liver antigen in autoimmune hepatitis:A PRISMA-compliant meta-analysis[J]. Medicine(Baltimore),2015,94(23):e953.

[24] MONTANO-LOZA AJ,SHUMS Z,NORMAN GL,et al. Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis[J]. Liver Int,2012,32(1):85-92.

[25] LONGHI MS,HUSSAIN MJ,BOGDANOS DP,et al. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2[J]. Hepatology,2007,46(2):472-484.

[26] GORDON V,ADHIKARY R,APPLEBY V,et al. Diagnosis,presentation and initial severity of autoimmune hepatitis(AIH)in patients attending 28 hospitals in the UK[J]. Liver Int,2018,38(9):1686-1695.

[27] HAN Y,YAN HP,LIAO HY,et al. Clinical value of anti-liver/kidney microsomal-1 antibody in patients with liver disease[J]. Chin J Hepatol,2017,25(11):852-857.(in Chinese)韩莹，闫惠平，廖慧钰，等．抗肝肾微粒体抗体在肝病患者中的临床意义评价[J]．中华肝脏病杂志，2017,25(11):852-857.

[28] CLEMENTE MG,ANTONUCCI R,MANDATO C,et al. Autoantibodies against CYP-2C19:A novel serum marker in pediatric de novo autoimmune hepatitis?[J]. Biomed Res Int,2017,2017:3563278.

施引文献

资源附件(0)

访问统计